E-DRUG Free access to eMaLAM
Friends,
Recent editions of the MaLAM International Newsletter have included:
The memoirs of a former drug company employee regarding the methods he saw
being used to sell drugs.
and
Boehringer Ingelheim promotes Atrovent (ipratropium bromide) in Russia as
first line for chronic bronchitis.
If you have Internet www access then you can receive MaLAM International
Editions for free by sending an e-mail to
mintwww-request@list.camtech.net.au
with the word "subscribe" in the body of your message with out the quotation
marks and with no other text. Then you will receive e-mail notification of
new editions on our web site about once every 2 months.
If you do NOT have Internet www access then you can receive MaLAM
International Editions for free by sending an e-mail to
mintemail-request@list.camtech.net.au
with the word "subscribe" in the body of your message with out the quotation
marks and with no other text. Then you will receive a long e-mail message
about once every 2 months with the text of the edition but no formatting or
pictures.
If you want to read the recent editions then visit
www.camtech.net.au/malam/Inter.htm
If you can not do that (because you do not Internet www access) and want the
text of those editions then contact me directly.
regards,
Dr Peter Mansfield
GP
Director, MaLAM (Medical Lobby for Appropriate Marketing)
MaLAM aims to protect compassionate scientific health care from marketing
practices that may be detrimental to health.
peter.mansfield@flinders.edu.au
www.camtech.net.au/malam
PO Box 172 Daw Pk SA 5041 Australia
ph/fax +61 8 8374 2245
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.